This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drugdevelopment. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drugdevelopment. Learn more at koneksahealth.com.
About Koneksa Koneksa is a healthcaretechnology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drugdevelopment and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.
With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today! In 2011, the Jeopardy!-winning
Health Policy: The impact of healthcare policy on patient outcomes and access to care. The future of healthcare financing and payment models. The role of government and private sector in shaping the future of healthcare. Investment Strategy: The investment landscape for healthcare startups and emerging technologies.
“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drugdevelopment in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk
Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!
Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.
The conference explored the advancements in precision medicine and its implications for healthcare delivery. Biopharma Innovation and DrugDevelopment: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Subscribe Today!
Exec Summary: Chief Artificial Intelligence Officers (CAIOs) are a new but increasingly important role in healthcare. However, these early successes provide a promising outlook for the role and its potential to revolutionise healthcare with the responsible use of AI. Subscribe Today!
The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drugdevelopment. link] HealthcareTechnology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Healthcare AI can adopt similar strategies to integrate and analyse diverse patient data, including medical records, environmental factors, genetic data, and sensor data from wearables. Healthcare AI can learn several valuable things from weather AI: 1. Visit www.nelsonadvisors.co.uk Visit www.nelsonadvisors.co.uk
Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] HealthcareTechnology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!
Corporate Development for HealthcareTechnology companies in EMEA HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Focus on Chronic Wounds: Chronic wounds, such as diabetic ulcers and pressure ulcers, remain a significant healthcare challenge. The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Subscribe Today!
Technological advancements: New technologies offer more personalised, data-driven, and effective pain management strategies. Value-based care models: Emphasis on cost-effective and evidence-based pain management strategies. Telehealth: Remote consultations and monitoring for improved accessibility and convenience.
Mountain Group Partners’ investment strategy has always focused squarely on supporting companies like AngelEye Heath that are developing transformational technologies that improve the lives of others,” said Byron Smith , Managing Director at Mountain Group Partners. For more information, visit www.mtngp.com.
Exec Summary: The concept of a UK sovereign health fund based on NHS data is still in its early stages of development, but it has the potential to revolutionize the way healthcare is funded and delivered in the UK. The global drugdevelopment market is estimated to surpass $100bn by 2027. The value lies in sharing safely."
These algorithms utilize advanced machine learning techniques to sift through extensive patient data, including medical images, genetic information, and electronic health records, enabling healthcare providers to make more informed and timely diagnoses. What are the benefits of AI in drugdevelopment?
Working as a network rather than in silos, we can tackle inefficiencies in our healthcare system to drive better outcomes. But this shift can redefine the way healthcare providers engage with patients, driving a more dynamic, agile, and patient-centered model of care delivery.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content